Cite
Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
MLA
Byunghyun Park, et al. “Sphingosylphosphorylcholine Inhibits Plasma Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.” Frontiers in Immunology, July 2023, pp. 1–11. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1151511.
APA
Byunghyun Park, Yu Sun Jeong, Wonseok Hu, Mingyu Lee, Ji Cheol Kim, Geon Ho Bae, Yong-Soo Bae, & Yoe-Sik Bae. (2023). Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Frontiers in Immunology, 1–11. https://doi.org/10.3389/fimmu.2023.1151511
Chicago
Byunghyun Park, Yu Sun Jeong, Wonseok Hu, Mingyu Lee, Ji Cheol Kim, Geon Ho Bae, Yong-Soo Bae, and Yoe-Sik Bae. 2023. “Sphingosylphosphorylcholine Inhibits Plasma Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.” Frontiers in Immunology, July, 1–11. doi:10.3389/fimmu.2023.1151511.